https://www.selleckchem.com/pr....oducts/afuresertib-g
es of second-line chemotherapy. To evaluate the choroidal changes in Sturge-Weber syndrome (SWS) secondary glaucoma and non-glaucoma port-wine stain (PWS) patients by enhanced depth imaging optical coherence tomography (EDI-OCT). SWS and PWS patients who were over 3 years old and treated or screened at our ophthalmology department were included in the study. Baseline demographics, EDI-OCT and fundus photography data were collected from all patients. Overall, 46 non-glaucoma PWS (NGPWS) patients and 35 SWS secondary glauco
Like
Comment
Share
